180 Life Sciences Corp. Announces Closing of $11.7 Million Private Placement
MENLO PARK, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in Phase...
180 Life Sciences Corp. Announces $11.7 Million Private Placement
MENLO PARK, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in Phase...
180 Life Sciences Corp. to Present at the H.C. Wainwright Bioconnect 2021 Conference
MENLO PARK, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:Â ATNF)Â (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in...